148 related articles for article (PubMed ID: 29106503)
1. Induction of non-apoptotic programmed cell death by oncogenic RAS in human epithelial cells and its suppression by MYC overexpression.
Dendo K; Yugawa T; Nakahara T; Ohno SI; Goshima N; Arakawa H; Kiyono T
Carcinogenesis; 2018 Feb; 39(2):202-213. PubMed ID: 29106503
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
[TBL] [Abstract][Full Text] [Related]
3. Induction of nonapoptotic cell death by activated Ras requires inverse regulation of Rac1 and Arf6.
Bhanot H; Young AM; Overmeyer JH; Maltese WA
Mol Cancer Res; 2010 Oct; 8(10):1358-74. PubMed ID: 20713492
[TBL] [Abstract][Full Text] [Related]
4. Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibition.
Xu S; Spencer CM; Munger J
J Virol; 2015 Jun; 89(12):6406-17. PubMed ID: 25855740
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell death.
Byun JY; Kim MJ; Yoon CH; Cha H; Yoon G; Lee SJ
Mol Cancer Res; 2009 Sep; 7(9):1534-42. PubMed ID: 19723872
[TBL] [Abstract][Full Text] [Related]
6. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
7. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.
Rak J; Mitsuhashi Y; Erdos V; Huang SN; Filmus J; Kerbel RS
J Cell Biol; 1995 Dec; 131(6 Pt 1):1587-98. PubMed ID: 8522614
[TBL] [Abstract][Full Text] [Related]
8. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
Ozsvari B; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
[TBL] [Abstract][Full Text] [Related]
9. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression.
Wang Q; Tan R; Zhu X; Zhang Y; Tan Z; Su B; Li Y
Oncotarget; 2016 Mar; 7(9):10064-72. PubMed ID: 26848526
[TBL] [Abstract][Full Text] [Related]
12. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress.
Maya-Mendoza A; Ostrakova J; Kosar M; Hall A; Duskova P; Mistrik M; Merchut-Maya JM; Hodny Z; Bartkova J; Christensen C; Bartek J
Mol Oncol; 2015 Mar; 9(3):601-16. PubMed ID: 25435281
[TBL] [Abstract][Full Text] [Related]
13. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
[TBL] [Abstract][Full Text] [Related]
14. Active ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis.
Overmeyer JH; Kaul A; Johnson EE; Maltese WA
Mol Cancer Res; 2008 Jun; 6(6):965-77. PubMed ID: 18567800
[TBL] [Abstract][Full Text] [Related]
15. A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS.
Narisawa-Saito M; Inagawa Y; Yoshimatsu Y; Haga K; Tanaka K; Egawa N; Ohno S; Ichikawa H; Yugawa T; Fujita M; Kiyono T
Carcinogenesis; 2012 Apr; 33(4):910-7. PubMed ID: 22345164
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
17. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
Patel PL; Suram A; Mirani N; Bischof O; Herbig U
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
[TBL] [Abstract][Full Text] [Related]
18. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization.
Partanen JI; Nieminen AI; Mäkelä TP; Klefstrom J
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14694-9. PubMed ID: 17766436
[TBL] [Abstract][Full Text] [Related]
19. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
20. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
